300595 Stock Overview
Provides eye health and myopia prevention, and control technology and services in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
Autek China Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥18.68 |
| 52 Week High | CN¥24.86 |
| 52 Week Low | CN¥13.03 |
| Beta | 0.87 |
| 1 Month Change | -5.32% |
| 3 Month Change | 37.76% |
| 1 Year Change | -14.31% |
| 3 Year Change | -69.05% |
| 5 Year Change | -16.32% |
| Change since IPO | 567.19% |
Recent News & Updates
Is Autek China Inc. (SZSE:300595) Potentially Undervalued?
Nov 11
Autek China (SZSE:300595) Might Be Having Difficulty Using Its Capital Effectively
Oct 14Recent updates
Is Autek China Inc. (SZSE:300595) Potentially Undervalued?
Nov 11Autek China (SZSE:300595) Might Be Having Difficulty Using Its Capital Effectively
Oct 14Autek China Inc.'s (SZSE:300595) Shares Climb 44% But Its Business Is Yet to Catch Up
Sep 30Autek China Inc. (SZSE:300595) Shares Could Be 49% Below Their Intrinsic Value Estimate
Sep 01Little Excitement Around Autek China Inc.'s (SZSE:300595) Earnings
Aug 14Be Wary Of Autek China (SZSE:300595) And Its Returns On Capital
Jul 04Autek China (SZSE:300595) Has Announced That It Will Be Increasing Its Dividend To CN¥0.223
May 14We Think Autek China (SZSE:300595) Can Manage Its Debt With Ease
Apr 16An Intrinsic Calculation For Autek China Inc. (SZSE:300595) Suggests It's 28% Undervalued
Mar 22Autek China Inc.'s (SZSE:300595) 25% Price Boost Is Out Of Tune With Earnings
Mar 04There Are Reasons To Feel Uneasy About Autek China's (SZSE:300595) Returns On Capital
Mar 01Shareholder Returns
| 300595 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | -1.9% | -5.2% | -3.5% |
| 1Y | -14.3% | -10.3% | 10.9% |
Return vs Industry: 300595 underperformed the CN Medical Equipment industry which returned -10.3% over the past year.
Return vs Market: 300595 underperformed the CN Market which returned 10.9% over the past year.
Price Volatility
| 300595 volatility | |
|---|---|
| 300595 Average Weekly Movement | 11.4% |
| Medical Equipment Industry Average Movement | 8.5% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 300595's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 300595's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 3,229 | Yuequn Tao | www.orthok.cn |
Autek China Inc. provides eye health and myopia prevention, and control technology and services in China. The company operates through Ophthalmology Services; and Products segments. It also offers ophthalmic and optometry medical devices.
Autek China Inc. Fundamentals Summary
| 300595 fundamental statistics | |
|---|---|
| Market cap | CN¥16.75b |
| Earnings (TTM) | CN¥651.13m |
| Revenue (TTM) | CN¥1.85b |
25.7x
P/E Ratio9.1x
P/S RatioIs 300595 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300595 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.85b |
| Cost of Revenue | CN¥492.90m |
| Gross Profit | CN¥1.36b |
| Other Expenses | CN¥704.56m |
| Earnings | CN¥651.13m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.73 |
| Gross Margin | 73.34% |
| Net Profit Margin | 35.22% |
| Debt/Equity Ratio | 0.3% |
How did 300595 perform over the long term?
See historical performance and comparisonDividends
1.2%
Current Dividend Yield31%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 20:14 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Autek China Inc. is covered by 14 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Bo Li | BofA Global Research |
| Yichi Zhang | China International Capital Corporation Limited |
| Bin Wu | China Merchants Securities Co. Ltd. |